Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode
Authors:
Open Access
- 23 July 2022
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 269 (12) , 6366-6376
Abstract
Background: Optic neuritis (ON) is the most prevalent manifestation of pediatric multiple sclerosis (MSped) and myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGADped) in children > 6 years. In this study, we investigated retinal atrophy patterns and diagnostic accuracy of optical coherence tomography (OCT) in differentiating between both diseases after the first ON episode. Methods: Patients were retrospectively identified in eight tertial referral centers. OCT, VEP and high/low-contrast visual acuity (HCVA/LCVA) have been investigated > 6 months after the first ON. Prevalence of pathological OCT findings was identified based on data of 144 age-matched healthy controls. Results: Thirteen MOGADped (10.7 ± 4.2 years, F:M 8:5, 21 ON eyes) and 21 MSped (14.3 ± 2.4 years, F:M 19:2, 24 ON eyes) patients were recruited. We observed a significantly more profound atrophy of both peripapillary and macular retinal nerve fiber layer in MOGADped compared to MSped (pRNFL global: 68.2 ± 16.9 vs. 89.4 ± 12.3 µm, p < 0.001; mRNFL: 0.12 ± 0.01 vs. 0.14 ± 0.01 mm3, p < 0.001). Neither other macular layers nor P100 latency differed. MOGADped developed global atrophy affecting all peripapillary segments, while MSped displayed predominantly temporal thinning. Nasal pRNFL allowed differentiation between both diseases with the highest diagnostic accuracy (AUC = 0.902, cutoff < 62.5 µm, 90.5% sensitivity and 70.8% specificity for MOGADped). OCT was also substantially more sensitive compared to VEP in identification of ON eyes in MOGAD (pathological findings in 90% vs. 14%, p = 0.016). Conclusion: First MOGAD-ON results in a more severe global peripapillary atrophy compared to predominantly temporal thinning in MS-ON. Nasal pRNFL allows differentiation between both diseases with the highest accuracy, supporting the additional diagnostic value of OCT in children with ON.Keywords
Funding Information
- Universitätsklinikum der Ruhr-Universität Bochum
This publication has 39 references indexed in Scilit:
- ISCEV standard for clinical visual evoked potentials: (2016 update)Documenta Ophthalmologica, 2016
- The APOSTEL recommendations for reporting quantitative optical coherence tomography studiesNeurology, 2016
- A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosisMultiple Sclerosis Journal, 2015
- Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomographyMultiple Sclerosis Journal, 2015
- Immunoglobulin G antibodies to the N‐Methyl‐D‐aspartate receptor are distinct from immunoglobulin A and immunoglobulin M responsesAnnals of Neurology, 2014
- Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteriaMultiple Sclerosis Journal, 2014
- Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosisMultiple Sclerosis and Related Disorders, 2014
- Normative Reference Ranges for the Retinal Nerve Fiber Layer, Macula, and Retinal Layer Thicknesses in ChildrenAmerican Journal of Ophthalmology, 2013
- Anti–Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Patients With Optic NeuritisArchives of Neurology, 2012
- Relation of Visual Function to Retinal Nerve Fiber Layer Thickness in Multiple SclerosisOphthalmology, 2006